Sign in
  Edit search
The anti-CD20 antibody rituximab reduces the Th17 cell respo…
The anti-CD20 antibody rituximab reduces the Th17 cell response
The anti-CD20 antibody rituximab reduces the Th17 cell response
Article, Chapter
Authors: F.L. van de Veerdonk
Publication: Arthritis and Rheumatism, Volume:63, Issue:6
Published: Wiley, 2011
ISSN: 0004-3591
  Full text availability for this item
View Full Text Source:Arthritis and Rheumatism,Arthritis and Rheumatism,Wiley Online Library Database Model 2021 Opens in new Window
Journal:  Arthritis and Rheumatism Source:Wiley Online Library Database Model 2021 Opens in new Window
Collection:  Wiley Online Library Database Model 2021 Opens in new Window
Coverage:
  • 1999~2013; volume:42;issue:1~volume:65;issue:12
View Full Text Source:Arthritis and Rheumatism,Arthritis and Rheumatism,Wiley Online Library: Complete Journals Opens in new Window
Journal:  Arthritis and Rheumatism Source:Wiley Online Library: Complete Journals Opens in new Window
Collection:  Wiley Online Library: Complete Journals Opens in new Window
Coverage:
  • 1958-02-01~2013-12-01; volume:1;issue:1~volume:65;issue:12
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item